Computational Insights into Dopamine-Mediated Conformational Transitions of Aβ Aggregates in Alzheimer’s Disease
ACS Chemical Neuroscience · 2025
DOI: 10.1021/acschemneuro.5c00456 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Chemical Neuroscience, 2025. Verfasst von Sunandini Swain und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical and Biochemical Engineering, Indian Institute of Technology Patna, Patna-801106, India. Hauptthemen laut MEDLINE: Dopamine, Alzheimer Disease, Amyloid beta-Peptides. Die Arbeit nennt 64 Literaturangaben.
Themen: Demenz
Abstract (Originalsprache)
Alzheimer's disease (AD) is a looming neurological pandemic that affects over 57 million individuals globally and poses a challenge for the healthcare system due to its complex etiology and the fact that it remains incurable despite extensive research efforts. Among the various pathological contributors, dopaminergic dysfunction has emerged as a critical factor implicated in AD, causing apathy, depression, cognitive decline, and hallucinations, which significantly exacerbate disease progression and patient morbidity. Despite dopamine's multifarious role in modulating β-amyloid (Aβ) aggregation and in the pathogenesis of AD, the precise molecular interaction mechanism remains poorly understood. In this study, we employ molecular dynamics (MD) simulations to elucidate dopamine's conformation-specific interactions with Aβ across four hierarchical aggregation states: monomer, trimer, pentamer, and a nine-chain fibrillar assembly. This computational approach reveals that dopamine strongly perturbs the monomeric and trimeric forms, disrupting β-sheet structures and promoting α-helix formation. At the pentameric state, dopamine induces partial α-helix formation while weakening interchain hydrogen bonds and salt bridge interactions, indicating intermediate destabilization. In sharp divergence, the mature fibril exhibits structural rigidity with minimal conformational alteration and no disruption in the β-sheet content. These findings provide an advanced understanding of the conformation-dependent modulation mechanism whereby dopamine selectively interferes with the early nucleation phase rather than fibril elongation; also dopamine exhibits the most pronounced β-sheet disruption in monomers but shows progressively diminished efficacy in higher-order oligomeric and fibrillar assemblies. This selective interaction landscape highlights dopamine's potential as a modulator of early amyloidogenic events and offers novel insights for understanding dopamine-based therapeutic strategies for AD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemical and Biochemical Engineering, Indian Institute of Technology Patna, Patna-801106, India.
ORCID-Profile: Sunandini Swain, Atanu K Metya
Zitieren
APA
Swain, S., & Metya, A. K. (2025). Computational Insights into Dopamine-Mediated Conformational Transitions of Aβ Aggregates in Alzheimer’s Disease. ACS Chemical Neuroscience. https://doi.org/10.1021/acschemneuro.5c00456
Vancouver
Swain S, Metya AK. Computational Insights into Dopamine-Mediated Conformational Transitions of Aβ Aggregates in Alzheimer’s Disease. ACS Chemical Neuroscience. 2025. doi:10.1021/acschemneuro.5c00456
BibTeX
@article{Swain2025,
author = {Swain, Sunandini and Metya, Atanu K},
title = {Computational Insights into Dopamine-Mediated Conformational Transitions of Aβ Aggregates in Alzheimer’s Disease},
journal = {ACS Chemical Neuroscience},
year = {2025},
doi = {10.1021/acschemneuro.5c00456}
}
EUVIMED